Olimel N7 (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N7 is used as part of parenteral nutrition regimens to address amino acid deficiencies in clinical settings.

• Critical care patients: helps meet protein and nitrogen requirements during intensive care.
• Post‑operative recovery: supports tissue repair and wound healing after major surgery.
• Long‑term home parenteral nutrition: provides a balanced amino acid profile for patients unable to ingest adequate nutrition orally.
• Pediatric nutrition support: supplies essential amino acids for growth in children requiring intravenous feeding.

• The formulation delivers a balanced mixture of essential and non‑essential amino acids directly into the bloodstream, bypassing gastrointestinal absorption. These amino acids serve as substrates for protein synthesis, gluconeogenesis, and nitrogen balance, thereby supporting cellular metabolism, tissue repair and immune function in patients receiving parenteral nutrition.

Adverse reactions are generally related to the intravenous route and the amino‑acid composition.

Common Side Effects

• Mild fever or chills during infusion.
• Transient increase in blood urea nitrogen.
• Local irritation at the infusion site.
• Slight elevation of liver enzymes.
• Nausea or mild gastrointestinal discomfort.

Serious or Rare Side Effects

• Anaphylactic or severe hypersensitivity reaction.
• Hyperammonemia leading to neurologic symptoms.
• Metabolic acidosis.
• Severe electrolyte disturbances.
• Thrombophlebitis or catheter‑related infection.

When using Olimel N7, clinicians should assess patient-specific factors and monitor relevant parameters.

• Renal impairment: adjust infusion rate and monitor nitrogen waste.
• Hepatic dysfunction: watch for elevated ammonia and liver enzymes.
• Electrolyte balance: check serum electrolytes before and during therapy.
• Catheter care: maintain aseptic technique to prevent infection.
• Pregnancy and lactation: evaluate risk‑benefit ratio before use.

Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Olimel N7 may interact with other intravenous solutions or medications that affect nitrogen metabolism.

Major Interactions (Avoid)

• High‑dose nitrogenous waste scavengers (e.g., sodium phenylacetate) that could precipitate severe ammonia accumulation.
• Incompatible IV fluids containing calcium or phosphate that may cause precipitation.

Moderate Interactions (Monitor Closely)

• Loop diuretics that increase renal loss of electrolytes.
• Anticoagulants, as changes in plasma protein levels can affect coagulation monitoring.
• Insulin therapy, because amino acids stimulate insulin release.
• Other parenteral nutrition components, requiring careful formulation compatibility testing.